| Name | Title | Contact Details |
|---|
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Seniors for Living is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New York, NY. To find more information about Seniors for Living, please visit www.seniorsforliving.com
Greater Baltimore Medical Center Healthcare is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Greater Baltimore Medical Center Healthcare is based in Towson, MD. You can find more information on Greater Baltimore Medical Center Healthcare at www.gbmc.org
Molekule is a San Francisco-based science and clean technology start-up that has completely reinvented the air purifier using a revolutionary new technology.
PIAA Physicians Insurers Assoc of America is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.